SLC25A51 and acute myeloid leukemia: Recently, it was suggested that AML cells upregulate SLC25A51 to decouple the mitochondrial NAD+/NADH ratio, providing a proliferative [38, 39] advantage by supporting oxidative reactions from various fuels [40].